Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Experimental drug ISRIB might be effectual for reducing cognitive decline

Staff Writer
Staff Writer 2 years ago
Updated 2021/05/12 at 6:34 PM
Share
SHARE

An experimental drug known as ISRIB has drawn eyeballs from the medical community over its purported efficiency toward reducing age-related cognitive decline in a short span of time.

The findings of the new experimental treatment were released in the journal eLife.

Conducted by a team at the University of California, San Francisco, the drug’s alleged effectiveness was evident among rodents studied as part of laboratory studies, in which past research demonstrated its potential to treat other conditions as well.

According to the UC San Francisco team, laboratory studies of the experimental drug showed purported effectiveness in enhancing memory function following a traumatic brain injury or complications arising from Down syndrome.

The drug works by inhibiting or even reversing integrated stress response (ISR) activation occurring in the brain during aging, implicating the hippocampus, a region synonymous with learning and memory function.

“ISRIB’s extremely rapid effects show for the first time that a significant component of age-related cognitive losses may be caused by a kind of reversible physiological blockage rather than more permanent degradation,” co-author Susanna Rosi wrote in the news release.

“The data suggest that the aged brain has not permanently lost essential cognitive capacities, as was commonly assumed, but rather that these cognitive resources are still there but have been somehow blocked, trapped by a vicious cycle of cellular stress,” wrote co-author Peter Walter in the same report.

“Our work with ISRIB demonstrates a way to break that cycle and restore cognitive abilities that had become walled off over time,” Walter asserts.

Photo: spokesman.com

You Might Also Like

Study unveils the leisure activities that may lower the risk of dementia

MIT study shows how microglia can contribute to Alzheimer’s disease

New paper refutes theory that the human brain shrank 3,000 years ago

New study finds that people with autism are more skilled at reading emotions in cartoons

New research suggests smartphone use may enhance memory skills

TAGGED: ISRIB, aging, cognition, neuroscience
Staff Writer December 1, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Excessive smartphone usage may not be so bad for one’s mental health
Next Article How augmented reality could boost shopping during the holiday season

Recommended

Clinical

Study unveils the leisure activities that may lower the risk of dementia

1 Min Read
Clinical

MIT study shows how microglia can contribute to Alzheimer’s disease

1 Min Read
Clinical

New paper refutes theory that the human brain shrank 3,000 years ago

1 Min Read
Clinical

New study finds that people with autism are more skilled at reading emotions in cartoons

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?